"Ihre Gesundheit ist unser Ziel. In unserem modernen Universitätsklinikum vereinen wir medizinische Versorgung, intensive Forschung und umfangreiche Lehre zu Spitzenmedizin. Seit über 400 Jahren steht das Wohl der Patientinnen und Patienten am Universitätsklinikum Würzburg an erster Stelle. Hervorragend ausgebildete Teams und neueste Technologien sind unser Garant für Ihre Gesundheit. Spitzenqualität in Behandlung und Forschung zeichnen unser Klinikum aus. Von Ärztinnen und Ärzten über Krankenpflegerinnen und Krankenpfleger bis hin zur Verwaltung: Über 6300 Mitarbeiterinnen und Mitarbeiter kümmern sich tagtäglich um das Wohlbefinden unserer Patientinnen und Patienten. Damit Sie wieder gesund werden und auch gesund bleiben."

During the past decade, University Hospital Wuerzburg conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Wuerzburg" #1 sponsor was "Wuerzburg University Hospital" with 16 trials, followed by "Acacia Pharma Ltd" with 4 trials sponsored, "European Myeloma Network" with 3 trials sponsored, "Heidelberg University" with 3 trials sponsored and "University Hospital Tuebingen" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Wuerzburg" #1 collaborator was "Charite University, Berlin, Germany" with 3 trials as a collaborator, "Fiona Stanley Hospital" with 2 trials as a collaborator, "Hospital Universitario La Paz" with 2 trials as a collaborator, "World Hearing Centre" with 2 trials as a collaborator and "Wuerzburg University Hospital" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Wuerzburg" are "Adrenal Insufficiency" (5 trials), "Multiple Myeloma" (3 trials), "Hearing Loss" (2 trials), "Invasive Aspergillosis" (2 trials) and "Malignant Melanoma" (2 trials). Many other conditions were trialed in "University Hospital Wuerzburg" in a lesser frequency.

Most popular intervention types in "University Hospital Wuerzburg" are "Drug" (21 trials), "Other" (8 trials), "Diagnostic Test" (7 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "APD421" (3 trials), "CancerVax vaccine (CANVAXIN)" (2 trials), "Fludarabine" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Wuerzburg" are 54 trials for "All" genders.

Currently, there are 16 active trials in "University Hospital Wuerzburg". 1 are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in University Hospital Wuerzburg, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Wuerzburg, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".